BACKGROUND: One disadvantage of current loop recorders is the long interval between recording an electrocardiogram (ECG), establishing a diagnosis, and taking appropriate medical measures. The Cardio R loop recorder transmits cardiac recordings by cellular communication at the push of a button. Users can concomitantly relay symptoms, thereby providing a symptom/cardio-rhythm correlation. HYPOTHESIS: The Cardio R is capable of early detection of cardio-electrical events that could account for patients' symptoms. METHODS: This observational study was designed to evaluate patients who were referred from community physicians/cardiologists for evaluation of various cardiac symptoms that were not observed by regular office ECGs or traditional 24-hour Holter cardiac monitoring. Transmitted recordings were instantly displayed on a monitor for immediate diagnosis by the on-duty medical team at SHL-Telemedicine's call center. Abnormal tracings, especially when accompanied by symptoms selected from the prepared list, enabled the staff to instruct the subscriber, notify their physician, and/or dispatch a mobile intensive care unit to the scene. RESULTS: Between January 2009 and August 2010, there were 17 622 ECG transmissions received from 604 patients (age range, 10-95 years) who completed a 1-month trial with the Cardio R device. Palpitation, presyncope, and chest pain were the leading complaints. A disturbance in rhythm that could account for symptoms occurred during recording in 49% cases and was displayed within 7 minutes in 93% of them. No longer than 2 days elapsed from recording onset to diagnosis. CONCLUSIONS: The Cardio R device enables prompt ECG confirmation/exclusion of a probable arrhythmic cause of symptoms, enabling rapid intervention for cardiac-relevant complaints.
BACKGROUND: One disadvantage of current loop recorders is the long interval between recording an electrocardiogram (ECG), establishing a diagnosis, and taking appropriate medical measures. The Cardio R loop recorder transmits cardiac recordings by cellular communication at the push of a button. Users can concomitantly relay symptoms, thereby providing a symptom/cardio-rhythm correlation. HYPOTHESIS: The Cardio R is capable of early detection of cardio-electrical events that could account for patients' symptoms. METHODS: This observational study was designed to evaluate patients who were referred from community physicians/cardiologists for evaluation of various cardiac symptoms that were not observed by regular office ECGs or traditional 24-hour Holter cardiac monitoring. Transmitted recordings were instantly displayed on a monitor for immediate diagnosis by the on-duty medical team at SHL-Telemedicine's call center. Abnormal tracings, especially when accompanied by symptoms selected from the prepared list, enabled the staff to instruct the subscriber, notify their physician, and/or dispatch a mobile intensive care unit to the scene. RESULTS: Between January 2009 and August 2010, there were 17 622 ECG transmissions received from 604 patients (age range, 10-95 years) who completed a 1-month trial with the Cardio R device. Palpitation, presyncope, and chest pain were the leading complaints. A disturbance in rhythm that could account for symptoms occurred during recording in 49% cases and was displayed within 7 minutes in 93% of them. No longer than 2 days elapsed from recording onset to diagnosis. CONCLUSIONS: The Cardio R device enables prompt ECG confirmation/exclusion of a probable arrhythmic cause of symptoms, enabling rapid intervention for cardiac-relevant complaints.
Authors: Michele Brignole; Paolo Alboni; David G Benditt; Lennart Bergfeldt; Jean-Jacques Blanc; Paul Erik Bloch Thomsen; J Gert van Dijk; Adam Fitzpatrick; Stefan Hohnloser; Jean Janousek; Wishwa Kapoor; Rose Anne Kenny; Piotr Kulakowski; Giulio Masotti; Angel Moya; Antonio Raviele; Richard Sutton; George Theodorakis; Andrea Ungar; Wouter Wieling Journal: Europace Date: 2004-11 Impact factor: 5.214
Authors: Michele Brignole; Panos Vardas; Ellen Hoffman; Heikki Huikuri; Angel Moya; Renato Ricci; Neil Sulke; Wouter Wieling; Angelo Auricchio; Gregory Y H Lip; Jesus Almendral; Paulus Kirchhof; Etienne Aliot; Maurizio Gasparini; Frieder Braunschweig; Gregory Y H Lip; Jesus Almendral; Paulus Kirchhof; Gian Luca Botto Journal: Europace Date: 2009-05 Impact factor: 5.214
Authors: Edo Y Birati; Nomi Malov; Yevgeni Kogan; Yigal Yanay; Mira Tamari; Mayera Elizur; David M Steinberg; Michal Golovner; Arie Roth Journal: Resuscitation Date: 2008-10-25 Impact factor: 5.262
Authors: Arie Roth; Ori Rogowski; Yigal Yanay; Mayera Kehati; Nomi Malov; Michal Golovner Journal: Telemed J E Health Date: 2006-10 Impact factor: 3.536
Authors: S Viskin; M Golovner; N Malov; R Fish; I Alroy; Y Vila; S Laniado; E Kaplinsky; A Roth Journal: Eur Heart J Date: 1999-10 Impact factor: 29.983
Authors: Soori Sivakumaran; Andrew D Krahn; George J Klein; Jane Finan; Raymond Yee; Suzanne Renner; Allan C Skanes Journal: Am J Med Date: 2003-07 Impact factor: 4.965